Posted December 5, 2019

Joint Supplement Synovia Was Promoted With Phony Testimonials, Says FTC

A.S. Research, LLC, has agreed to settle Federal Trade Commission (FTC) charges that they deceived consumers with false claims that their dietary supplement Synovia could treat arthritis and alleviate joint pain. As part of the settlement, the company is barred from making false and unsubstantiated health claims about the product, and will pay $821,000 which may be used to refund consumers. 

According the FTC's complaint, Synovia was promoted through newspaper ads, bulk mailers, and on the company's website with misleading claims that the product could pave the "pot holes" in damaged joints, replace expensive injected medications, and reduce arthritis pain by 95 percent. Marketing materials also included phony testimonials, including one that showed a consumer who supposedly "gave away his walker" after using the supplement. 

In a press release about the settlement, the Director of the FTC's Bureau of Consumer Protection, Andrew Smith, stated," This company claimed to sell a miracle supplement that cured joint pain and arthritis, but they lied to consumers about the product's results and also used fake testimonials and fake doctor endorsements. He also warned, "If you lie about the effectiveness of your product, the FTC will hold you accountable." 

The settlement bans the defendants "from misrepresenting the results of any scientific study or endorsement and requires them to disclose any material connections they have with endorsers." It also imposes a $4.1 million judgment against A.S. Research which will be partially suspended after they pay $821,000. 

See ConsumerLab's Review of Joint Health Supplements for tests of related products.

See Related Recalls and Warnings:

Seller of TrueAloe and AloeCran Settles Charges of Making False Claims

Advocare to Pay $150 Million to Settle Charges of Operating a Pyramid Scheme

CVS Settles Lawsuit Over Claims Its Omega-3 Supplement Improves Memory

"Brain Boosting" Supplements Were Promoted With Non-Existent Clinical Studies

For more information, use the link below.